mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |